124 related articles for article (PubMed ID: 19558576)
1. Impact of experimental colitis on hepatobiliary transporter expression and bile duct injury in mice.
Jahnel J; Fickert P; Langner C; Högenauer C; Silbert D; Gumhold J; Fuchsbichler A; Trauner M
Liver Int; 2009 Oct; 29(9):1316-25. PubMed ID: 19558576
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis.
Baghdasaryan A; Fuchs CD; Österreicher CH; Lemberger UJ; Halilbasic E; Påhlman I; Graffner H; Krones E; Fickert P; Wahlström A; Ståhlman M; Paumgartner G; Marschall HU; Trauner M
J Hepatol; 2016 Mar; 64(3):674-81. PubMed ID: 26529078
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice.
Kok T; Bloks VW; Wolters H; Havinga R; Jansen PL; Staels B; Kuipers F
Biochem J; 2003 Feb; 369(Pt 3):539-47. PubMed ID: 12381268
[TBL] [Abstract][Full Text] [Related]
4. Bile acids modulate colonic MAdCAM-1 expression in a murine model of combined cholestasis and colitis.
Gao RY; Shearn CT; Orlicky DJ; Battista KD; Alexeev EE; Cartwright IM; Lanis JM; Kostelecky RE; Ju C; Colgan SP; Fennimore BP
Mucosal Immunol; 2021 Mar; 14(2):479-490. PubMed ID: 33004979
[TBL] [Abstract][Full Text] [Related]
5. CFTR dysfunction predisposes to fibrotic liver disease in a murine model.
Martin CR; Zaman MM; Ketwaroo GA; Bhutta AQ; Coronel E; Popov Y; Schuppan D; Freedman SD
Am J Physiol Gastrointest Liver Physiol; 2012 Aug; 303(4):G474-81. PubMed ID: 22679000
[TBL] [Abstract][Full Text] [Related]
6. Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases.
Zollner G; Fickert P; Zenz R; Fuchsbichler A; Stumptner C; Kenner L; Ferenci P; Stauber RE; Krejs GJ; Denk H; Zatloukal K; Trauner M
Hepatology; 2001 Mar; 33(3):633-46. PubMed ID: 11230744
[TBL] [Abstract][Full Text] [Related]
7. Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.
Fickert P; Fuchsbichler A; Wagner M; Zollner G; Kaser A; Tilg H; Krause R; Lammert F; Langner C; Zatloukal K; Marschall HU; Denk H; Trauner M
Gastroenterology; 2004 Jul; 127(1):261-74. PubMed ID: 15236191
[TBL] [Abstract][Full Text] [Related]
8. Tetrahydroxylated bile acids improve cholestatic liver and bile duct injury in the Mdr2
Fuchs CD; Dixon ED; Hendrikx T; Mlitz V; Wahlström A; Ståhlman M; Scharnagl H; Stojakovic T; Binder CJ; Marschall HU; Trauner M
Hepatol Commun; 2022 Sep; 6(9):2368-2378. PubMed ID: 35691019
[TBL] [Abstract][Full Text] [Related]
9. CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice.
Wagner M; Halilbasic E; Marschall HU; Zollner G; Fickert P; Langner C; Zatloukal K; Denk H; Trauner M
Hepatology; 2005 Aug; 42(2):420-30. PubMed ID: 15986414
[TBL] [Abstract][Full Text] [Related]
10. A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis.
Fickert P; Stöger U; Fuchsbichler A; Moustafa T; Marschall HU; Weiglein AH; Tsybrovskyy O; Jaeschke H; Zatloukal K; Denk H; Trauner M
Am J Pathol; 2007 Aug; 171(2):525-36. PubMed ID: 17600122
[TBL] [Abstract][Full Text] [Related]
11. Compensatory induction of liver efflux transporters in response to ANIT-induced liver injury is impaired in FXR-null mice.
Cui YJ; Aleksunes LM; Tanaka Y; Goedken MJ; Klaassen CD
Toxicol Sci; 2009 Jul; 110(1):47-60. PubMed ID: 19407337
[TBL] [Abstract][Full Text] [Related]
12. Hepatobiliary transporter expression in intercellular adhesion molecule 1 knockout and Fas receptor-deficient mice after common bile duct ligation is independent of the degree of inflammation and oxidative stress.
Wagner M; Zollner G; Fickert P; Gumhold J; Silbert D; Fuchsbichler A; Gujral JS; Zatloukal K; Denk H; Jaeschke H; Trauner M
Drug Metab Dispos; 2007 Sep; 35(9):1694-9. PubMed ID: 17576807
[TBL] [Abstract][Full Text] [Related]
13. ANIT-induced intrahepatic cholestasis alters hepatobiliary transporter expression via Nrf2-dependent and independent signaling.
Tanaka Y; Aleksunes LM; Cui YJ; Klaassen CD
Toxicol Sci; 2009 Apr; 108(2):247-57. PubMed ID: 19181614
[TBL] [Abstract][Full Text] [Related]
14. Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver.
Fickert P; Zollner G; Fuchsbichler A; Stumptner C; Pojer C; Zenz R; Lammert F; Stieger B; Meier PJ; Zatloukal K; Denk H; Trauner M
Gastroenterology; 2001 Jul; 121(1):170-83. PubMed ID: 11438506
[TBL] [Abstract][Full Text] [Related]
15. Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis.
Meng Q; Chen XL; Wang CY; Liu Q; Sun HJ; Sun PY; Huo XK; Liu ZH; Yao JH; Liu KX
Toxicol Appl Pharmacol; 2015 Mar; 283(3):178-86. PubMed ID: 25655198
[TBL] [Abstract][Full Text] [Related]
16. Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-κB-mediated inflammatory response in mice.
Fiorotto R; Scirpo R; Trauner M; Fabris L; Hoque R; Spirli C; Strazzabosco M
Gastroenterology; 2011 Oct; 141(4):1498-508, 1508.e1-5. PubMed ID: 21712022
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological inhibition of apical sodium-dependent bile acid transporter changes bile composition and blocks progression of sclerosing cholangitis in multidrug resistance 2 knockout mice.
Miethke AG; Zhang W; Simmons J; Taylor AE; Shi T; Shanmukhappa SK; Karns R; White S; Jegga AG; Lages CS; Nkinin S; Keller BT; Setchell KD
Hepatology; 2016 Feb; 63(2):512-23. PubMed ID: 26172874
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory cytokines, but not bile acids, regulate expression of murine hepatic anion transporters in endotoxemia.
Hartmann G; Cheung AK; Piquette-Miller M
J Pharmacol Exp Ther; 2002 Oct; 303(1):273-81. PubMed ID: 12235261
[TBL] [Abstract][Full Text] [Related]
19. Decreased peroxisome proliferator activated receptor alpha is associated with bile duct injury in cystic fibrosis transmembrane conductance regulator-/- mice.
Pall H; Zaman MM; Andersson C; Freedman SD
J Pediatr Gastroenterol Nutr; 2006 Mar; 42(3):275-81. PubMed ID: 16540796
[TBL] [Abstract][Full Text] [Related]
20. Colesevelam attenuates cholestatic liver and bile duct injury in
Fuchs CD; Paumgartner G; Mlitz V; Kunczer V; Halilbasic E; Leditznig N; Wahlström A; Ståhlman M; Thüringer A; Kashofer K; Stojakovic T; Marschall HU; Trauner M
Gut; 2018 Sep; 67(9):1683-1691. PubMed ID: 29636383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
